Conditions: Tourette's Disorder
Keywords: Tourette's Disorder Tic Disorders
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 170
Healthy volunteers: no

Brief summary:
The goal of the current trial is to obtain long term efficacy, safety and tolerability data of once weekly aripiprazole in children and adolescents with Tourette's Disorder.

Detailed description:

Arms:
arm 1: Participants received oral aripiprazole tablets once weekly (QW) with a titrated dose starting from 52.5 milligram (mg), on Day 1 and increasing to 77.5 mg and 110 mg for the remainder of the trial (Up to Week 52), the dose could be adjusted between these 3 dose levels as determined by investigator's discretion based on safety and tolerability.

Interventions: intervention 1: Aripiprazole
Intervention descriptions: intervention 1: Aripiprazole tablets orally once daily.

Protocol document: